PIMOZIDE

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID1493
Ligand NamePIMOZIDE
PubMed Compound Id16362
StructureProduct Image
Molecular FormulaC28H29F2N3O
Molecular Weight461.5
SMILESC1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F
Synonymspimozide
2062-78-4
Opiran
Pimozidum
pimozida
McN-JR-6238
Pimozidum [INN-Latin]
Primozida
R 6238
Primozida [INN-Spanish]
CCRIS 9172
2H-Benzimidazol-2-one, 1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-
NSC 170984
UNII-1HIZ4DL86F
EINECS 218-171-7
1HIZ4DL86F
NSC-170984
BRN 0729089
CHEBI:8212
1-(1-(4,4-Bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone
1-(4,4-Bis(p-fluorophenyl)butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine
NSC170984
1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone
2H-Benzimidazol-2-one, 1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-
R-623
5-24-02-00367 (Beilstein Handbook Reference)
Pimozide [USAN:USP:INN:BAN:JAN]
Pimozidum (INN-Latin)
Primozida (INN-Spanish)
PIMOZIDE (MART.)
PIMOZIDE [MART.]
PIMOZIDE (USP-RS)
PIMOZIDE [USP-RS]
1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one
PIMOZIDE (EP MONOGRAPH)
PIMOZIDE [EP MONOGRAPH]
PIMOZIDE (USP MONOGRAPH)
PIMOZIDE [USP MONOGRAPH]
Pimozide (USAN:USP:INN:BAN:JAN)
1-[4,4-Bis(p-fluorophenyl)butyl]-4-(2-oxo-1-benzimidazolinyl)piperidine
2H-BENZIMIDAZOL-2-ONE, 1-(1-(4,4-BIS(4-FLUOROPHENYL)BUTYL)-4-PIPERIDINYL)-1,3-DIHYDRO
1-[1-[4,4-Bis(4-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone
1-(1-(4,4-BIS(4-FLUOROPHENYL)BUTYL)-4-PIPERIDYL)-2-BENZIMIDAZOLINONE
1-(1-(4,4-Bis(4-fluorophenyl)butyl)piperidin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one
N05AG02
218-171-7
Orap
R-6238
R6238
McN-JR 6238
3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one
1-[1-[4,4-bis(4-Fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one
MFCD00055081
CHEMBL1423
MLS000028410
MLS002702058
DTXSID8023474
1-(1-(4,4-bis(4-fluorophenyl)butyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one
1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one
NCGC00015802-08
NCGC00015802-18
SMR000058385
CAS-2062-78-4
R 623
DTXCID803474
Primozide
Pimozida [INN-Spanish]
3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1~{H}-benzimidazol-2-one
Orap (TN)
SR-01000075392
Pimozide?
1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-2H-benzimidazol-2-one
Prestwick_395
Pimozide (Standard)
Spectrum_000445
Tocris-0937
PIMOZIDE [USAN]
PIMOZIDE [INN]
PIMOZIDE [JAN]
PIMOZIDE [MI]
PIMOZIDE [VANDF]
Opera_ID_1580
Prestwick0_000308
Prestwick1_000308
Prestwick2_000308
Prestwick3_000308
Spectrum2_001026
Spectrum3_001451
Spectrum4_000420
Spectrum5_001308
Lopac-P-1793
GTPL90
PIMOZIDE [WHO-DD]
NCIMech_000356
P 1793
Lopac0_000946
SCHEMBL41584
BSPBio_000276
BSPBio_001439
BSPBio_002941
KBioGR_000720
KBioSS_000925
MLS001077311
BIDD:GT0435
DivK1c_000386
SPECTRUM1501134
Pimozide (JP18/USP/INN)
SPBio_001211
SPBio_002495
PIMOZIDE [ORANGE BOOK]
BPBio1_000304
SCHEMBL7519553
BCBcMAP01_000043
HMS501D08
KBio1_000386
KBio2_000925
KBio2_003493
KBio2_006061
KBio3_002441
NINDS_000386
GLXC-06097
HMS1568N18
HMS1791H21
HMS1921H19
HMS1989H21
HMS2089C11
HMS2092F09
HMS2095N18
HMS2231P23
HMS3262N14
HMS3267E19
HMS3370N13
HMS3402H21
HMS3411J16
HMS3675J16
HMS3712N18
Pharmakon1600-01501134
DXC19357
Tox21_110224
Tox21_301586
Tox21_500946
BDBM50334150
CCG-35918
CCG-36461
CCG-39728
EX-A10246
HY-12987R
NSC757854
s4358
2-Benzimidazolinone, 1-[1-[4,4-bis(p-fluorophenyl)butyl]-4-piperidyl]-
3-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidyl]-1H-benzimidazol-2-one
AKOS024458706
Tox21_110224_1
DB01100
FP63878
LP00946
NSC-757854
SDCCGSBI-0050920.P004
IDI1_000386
SMP1_000241
NCGC00015802-01
NCGC00015802-02
NCGC00015802-03
NCGC00015802-04
NCGC00015802-05
NCGC00015802-06
NCGC00015802-07
NCGC00015802-09
NCGC00015802-10
NCGC00015802-11
NCGC00015802-12
NCGC00015802-13
NCGC00015802-14
NCGC00015802-15
NCGC00015802-16
NCGC00015802-26
NCGC00015802-29
NCGC00016601-01
NCGC00022282-03
NCGC00024888-01
NCGC00024888-02
NCGC00024888-03
NCGC00024888-04
NCGC00024888-05
NCGC00024888-06
NCGC00024888-07
NCGC00255294-01
NCGC00261631-01
AS-13916
DA-56876
HY-12987
SBI-0050920.P003
AB00052215
CS-0012921
EU-0100946
NS00003971
SW196639-3
C07566
D00560
EN300-127038
F70142
AB00052215-06
AB00052215_07
AB00052215_08
L000494
Q144085
WLN: T56 BMVNJ D- DT6NTJ A3YR DF&R DF
SR-01000075392-1
SR-01000075392-3
SR-01000075392-4
SR-01000075392-6
BRD-K01292756-001-06-0
BRD-K01292756-001-13-6
BRD-K01292756-001-23-5
BRD-K01292756-001-24-3
BRD-K01292756-001-25-0
Pimozide, European Pharmacopoeia (EP) Reference Standard
2-Benzimidazolinone,4-bis(p-fluorophenyl)butyl]-4-piperidyl]-
N-benzyl-N-(3-isobutoxy-2-(pyrrolidin-1-yl)propyl)benzenamine
Pimozide, United States Pharmacopeia (USP) Reference Standard
1-[1-[4,4-Bis(p-flurophenyl)butyl]-4-piperidyl]-2-benzimidazolinone
1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2h-benzimidazole-2-one
1-{1-[4,4-bis-(4-fluoro-phenyl)-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one
2H-Benzimidazol-2-one,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-
1-{1-[4,4-Bis-(4-fluoro-phenyl)-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one(Pimozide)
Pimozide (1-[1-[4,4-Bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidaol-2-one)
PIMOZIDE1-{1-[4,4-BIS-(4-FLUORO-PHENYL)-BUTYL]-PIPERIDIN-4-YL}-1,3-DIHYDRO-BENZOIMIDAZOL-2-ONE
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm